The 59 end of eukaryotic mRNA contains the type-1 (m7GpppNm) or type-2 (m7GpppNmNm) cap structure. Many viruses have evolved various mechanisms to develop their own capping enzymes (e.g. flavivirus and coronavirus) or to 'steal' caps from host mRNAs (e.g. influenza virus). Other viruses have developed 'cap-mimicking' mechanisms by attaching a peptide to the 59 end of viral RNA (e.g. picornavirus and calicivirus) or by having a complex 59 RNA structure (internal ribosome entry site) for translation initiation (e.g. picornavirus, pestivirus and hepacivirus). Here we review the diverse viral RNA capping mechanisms. Using flavivirus as a model, we summarize how a single methyltransferase catalyses two distinct N-7 and 29-O methylations of viral RNA cap in a sequential manner. For antiviral development, a structural feature unique to the flavivirus methyltransferase was successfully used to design selective inhibitors that block viral methyltransferase without affecting host methyltransferases. Functionally, capping is essential for prevention of triphosphate-triggered innate immune activation; N-7 methylation is critical for enhancement of viral translation; and 29-O methylation is important for subversion of innate immune response during viral infection. Flaviviruses defective in 29-O methyltransferase are replicative, but their viral RNAs lack 29-O methylation and are recognized and eliminated by the host immune response. Such mutant viruses could be rationally designed as live attenuated vaccines. This concept has recently been proved with Japanese encephalitis virus and dengue virus. The findings obtained with flavivirus should be applicable to other RNA viruses.
Introduction
The 59 ends of almost all eukaryotic cellular mRNAs possess a cap structure, which consists of an N-7 methylguanosine (m7G) moiety linked to the first nucleotide of the nascent mRNA via a 59-59 inverted triphosphate bridge (Fig. 1a ). The cap structure plays important roles in mRNA splicing, intracellular RNA transport, RNA stability and turnover, and recognition by eukaryotic translation initiation factor 4E (eIF4E) for efficient translation (Banerjee, 1980; Furuichi & Shatkin, 2000; Ghosh & Lima, 2010) . The cap structure of mRNA is co-transcriptionally formed through three sequential enzymic reactions in the nucleus (Shuman, 2001) (Fig. 1b) : (i) an RNA triphosphatase (RTPase) removes the c-phosphate from the 59-triphosphate end of the nascent RNA to generate 59-diphosphate RNA (pppN-RNAAppN-RNA); (ii) an RNA guanylyltransferase (GTase) transfers the GMP moiety from GTP to ppN-RNA to yield the cap core structure (GTP+ppN-RNAAGpppN-RNA); and (iii) an RNA guanine-methyltransferase (N-7 MTase) methylates the guanine at the N-7 position to produce a type-0 cap structure (m7GpppN-RNA). The type-0 cap is only found in metazoan and lower eukaryotes. In higher eukaryotes, m7GpppN-RNA is further methylated at the ribose 29-O position of the nascent mRNA by a ribose 29-O methyltransferase (29-O MTase) to form mainly type-1 (m7GpppNm) and also type-2 (m7GpppNmNm) cap structures. Both 29-O MTase and N-7 MTase use S-adenosyl-L-methionine (SAM) as the methyl donor and generate S-adenosyl-L-homocysteine (SAH) as a by-product (Fig. 1c ).
Most viruses carry the same type-1 cap structure as cellular mRNA. Since many RNA viruses replicate in the cytoplasm, they do not have access to the host capping machinery located in the nucleus. Therefore, these viruses have evolved to encode their own capping apparatus, many of which are different from the canonical capping pathway of host mRNA as described above. The function of each element of viral RNA cap (m7GpppNm) has been determined: (i) the guanosine cap core structure protects the 59 triphosphates from activating the host innate immune response (Pichlmair et al., 2006) ; (ii) the N-7 methylation is essential for viral replication through enhancement of viral RNA translation (Ray et al., 2006) ; and (iii) the 29-O methylation functions to evade the host immune response by mimicking cellular mRNA (Daffis et al., 2010; Züst et al., 2011) . The essential functions of viral RNA cap and methylation, together with distinct mechanisms between host RNA cap formation and viral RNA cap formation (which allows design of inhibitors that selectively block the viral RNA cap formation without affecting the host RNA cap formation), have opened new opportunities for vaccine and antiviral development.
Here we review the current understanding of diverse viral RNA capping mechanisms. We summarize the recent progress in flavivirus RNA methylation and its use as a target for antiviral and vaccine development. The capping of viral mRNA from DNA viruses (such as vaccinia virus) is not described here. Interested readers are encouraged to read a broader review on the capping mechanisms of viral mRNA (Decroly et al., 2012) .
Distinct capping pathways of RNA viruses

Flavivirus
Viruses from the genus Flavivirus within the family Flaviviridae contain a single-strand, plus-sense RNA genome of approximately 11 kb. Flavivirus replicates in the cytoplasm without entering the nucleus, and encodes its own capping enzymes. The cap formation of flavivirus RNA follows the conventional pathway of eukaryotic mRNA cap formation, through sequential enzymic actions of RTPase, GTase and MTase ( Fig. 2a ). Flavivirus RTPase has been mapped to the C-terminal domain of non-structural protein 3 (NS3) (Li et al., 1999; Wengler & Wengler, 1991) . Three studies suggest that the GTase may reside in the MTase domain of NS5 (Bollati et al., 2009; Egloff et al., 2007b; Issur et al., 2009) ; however, more studies are needed to clearly demonstrate the full activity of GTase of flavivirus NS5. The N-7 and 29-O MTases have been located to the N-terminal domain of NS5 (Egloff et al., 2002a; Ray et al., 2006; Zhou et al., 2007) .
Alphavirus
The RNA cap formation of alphavirus, a group of plus-strand RNA viruses within the family Togaviridae, follows an unconventional mechanism (Fig. 2b) . As exemplified by Semliki Forest virus (SFV), the viral RNA capping takes place in the cytoplasm. Viral nsP2 functions as RTPase cleaving the b-c phosphate bond at the 59 end of viral RNA to form ppN-RNA (Vasiljeva et al., 2000) . nsP1, possessing N-7 MTase and GTase activities, catalyses the transfer of a methyl group from SAM to the N-7 position of GTP to yield m7GTP before formation of the covalent m7GMP-enzyme (m7GMP-nsP1) complex. Type-0 cap m7GpppN-RNA is formed by transferring m7GMP to ppN-RNA (Ahola & Kääriäinen, 1995; Ahola et al., 1997) RNA; instead, a methyl group is transferred to the exocyclic N2 position of the cap structure in SFV (van Duijn et al., 1986) ; the function of this methylation remains unclear. Since alphavirus RNA does not have 29-O methylation, the N2 methylation or an unidentified mechanism may play a role in subverting host innate immune response during viral infection.
Coronavirus
Members from the family Coronaviridae produce mRNAs with a type-1 cap structure (Lai et al., 1982; Lai & Stohlman, 1981) . It has been predicted that nsp13 has an RTPase activity (Ivanov et al., 2004; Ivanov & Ziebuhr, 2004) , but direct evidence of nsp13 in performing the Alphavirus cap formation (exemplified by SFV). Alphavirus nsP1 possesses both N-7 MTase and GTase activities; nsP1 catalyses N-7 methylation of GTP to generate m7GTP. The m7GMP moiety of m7GTP is then transferred to ppN-RNA, resulting in m7Gp-ppN-RNA. The m7Gp-ppN-RNA of alphavirus is not further methylated at the ribose 29-O position of the first nucleotide of RNA. (c) Rhabdovirus cap formation (exemplified by VSV). GTP is first hydrolysed to GDP by an unidentified NTPase (indicated by '?'). The 59-monophosphorylated viral mRNA is transferred to the GDP by a PRNTase, generating Gpp-pA-RNA. The RNA cap is then subjected to 29-O and N-7 methylations in a sequential manner by the L protein of VSV. (d) Influenza virus cap formation. Influenza virus polymerase contains three subunits: PA, PB1 and PB2. The PB2 subunit binds to the 59 end of capped cellular mRNA; the PA subunit (containing an EndoN activity) cleaves the 59-capped RNA fragment from the cellular mRNA; the cleaved short capped mRNA is used as a primer to synthesize nascent viral mRNA by PB1. RdRp, RNAdependent RNA polymerase.
RTPase activity remains to be demonstrated. The GTase activity for coronavirus remains elusive. The N-7 MTase of severe acute respiratory syndrome coronavirus was mapped to nsp14 . Using nsp10 as a co-factor, nsp16 acts as a 29-O MTase; the nsp10 activates nsp16 29-O MTase activity by facilitating nsp16 to bind m7GpppA-RNA substrate and the SAM donor (Bouvet et al., 2010; Chen et al., 2011; Decroly et al., 2011) . Notably, the nsp10/nsp16 can only methylate m7GpppA-RNA, not m7GpppG-RNA (Bouvet et al., 2010) , suggesting a specific recognition between the enzyme and RNA substrate during the 29-O methylation reaction. Specific recognition between MTase and RNA substrate has also been observed in flavivirus (see below) and Sendai virus, a member of the paramyxovirus subfamily (Ogino et al., 2005) .
Rhabdovirus
Viruses from family Rhabdoviridae and other families from the order Mononegavirales form their RNA cap through a mechanism that is completely different from the cellular mRNA capping pathway. The cap formation of mRNA from these viruses is best characterized for vesicular stomatitis virus (VSV; from the family Rhabdoviridae) (Ogino & Banerjee, 2011) . During the VSV mRNA cap formation ( Fig. 2c ), GTP is hydrolysed to GDP by an asyet-unknown NTPase. The 59-monophosphorylated viral mRNA with the conserved vesiculoviral mRNA-start sequence is transferred to the GDP by a polyribonucleotidyltransferase (PRNTase), generating the Gpp-pA-RNA cap structure (Ogino & Banerjee, 2007; Ogino et al., 2010) . Next, the RNA cap is sequentially methylated at the ribose-29-O position and the guanine-N-7 position, resulting in m7GpppAm-RNA (Li et al., 2005 Rahmeh et al., 2009) . Both the PRNTase and MTase (including both 29-O and N-7 methylations) activities have been mapped to the L protein of VSV. Compared with the canonical pathway, the cap formation of VSV RNA exhibits three unique features. (i) The VSV capping enzyme transfers p-RNA to GDP, rather than GMP to pp-RNA. (ii) The PRNTase covalently binds to monophosphorylated mRNA to form the enzyme-pNp-RNA intermediate. Such covalent linkage involves a conserved His residue within an 'HR (His-Arg)' motif of PRNTase; in contrast, the conventional GTase uses a conserved lysine to covalently link to GMP during the enzyme-GMP intermediate formation. (iii) 29-O methylation of the VSV mRNA cap structure precedes N-7 methylation.
Influenza virus
Influenza virus and some other single-strand, negative-sense RNA viruses from families Orthomyxoviridae, Arenaviridae and Bunyaviridae have evolved to steal cap structure from host mRNA to generate their viral RNA cap. This mechanism, known as cap snatching, was first discovered in influenza virus (Bouloy et al., 1978) . The cap snatching during influenza virus replication is performed by viral polymerase which consists of three subunits (PA, PB1 and PB2) ( Fig. 2d ). Subunit PB2 binds to the 59 end of capped cellular mRNA (Fechter et al., 2003; Guilligay et al., 2008) ; the cellular mRNA is cleaved at 10-13 nt downstream from the cap structure by the viral endonuclease (EndoN) located at the N terminus of the PA subunit (Dias et al., 2009; Yuan et al., 2009) ; the released short capped mRNA is used as a primer by the viral polymerase to synthesize nascent viral mRNA. The sequence, length and structure of the 59 capped mRNA vary from one virus to the other.
Picornavirus and calicivirus
Viruses from the families Picornaviridae and Caliciviridae (both are single-stranded positive-sense RNA viruses) use a protein instead of a cap structure to initiate viral RNA transcription and to protect RNA from degradation. This phenomenon was first discovered in picornavirus (Flanegan et al., 1977; Lee et al., 1977) and later found in calicivirus (Schaffer et al., 1980) . The 59 end of viral RNA is covalently attached to a small basic protein VPg (viral protein genomelinked); the 59 VPg-pU-pU-RNA structure is formed between a phosphate from viral RNA and a conserved Tyr residue of VPg. During viral replication, the tyrosine hydroxyl group from VPg functions as a 'protein-primer' to produce VPg-linked polyU; the VPg-linked polyU then serves as a primer to synthesize RNA by viral polymerase (3D pol ) (Paul et al., 1998) . Several crystal structures of 3D pol in complex with VPg have been solved (Chen et al., 2013a; Ferrer-Orta et al., 2006; Gruez et al., 2008) ; these structures suggest that 3D pol from different picornaviruses may perform VPg uridylylation through distinct mechanisms. For viral translation, poliovirus utilizes an internal ribosome entry site (IRES) instead of a cap for translation initiation; therefore, VPg is not required for establishing the initial infection of poliovirus (Fitzgerald & Semler, 2009) . In contrast, calicivirus VPg protein interacts directly with the cap-binding protein of the ribosome, eIF4E. This interaction is essential for viral translation; therefore, calicivirus VPg acts as a 'cap substitute' during initiation of translation of viral mRNA (Goodfellow et al., 2005) .
Hepacivirus and pestivirus
The 59 ends of hepacivirus and pestivirus (two genera from the family Flaviviridae) genomic RNA do not carry a cap structure. Instead, they contain IRES to initiate viral translation in a cap-independent manner. The hepatitis C virus (HCV) IRES directly recruits the ribosome 40S subunit (ribosomal P-site) to the translation initiator codon of the genome without mRNA scanning; such IRES-mediated translation does not require eukaryotic initiation factors eIF1, 1A, 4A, 4B and 4E (Ló pez-Lastra et al., 2005) . Compared with HCV, the IRES from picornavirus differs significantly in both structure and functionality (Niepmann, 2013) . The picornavirus IRES does not directly attract the ribosomal 40S subunit, but rather does so through the highaffinity eIF-4G-binding site (Hellen & Sarnow, 2001) .
Because the 59 termini of both HCV and bovine viral diarrhea virus (a pestivirus) genomes contain an unprotected triphosphate, these RNAs are prone to trigger innate immune response. Consequently, these viruses have also evolved distinct mechanisms to limit and evade the antiviral response (Garaigorta & Chisari, 2009; Guidotti & Chisari, 2001) .
Flavivirus 5 § RNA cap methylation
Sequential N-7 and 29-O methylations of RNA cap
The current understanding of flavivirus RNA cap methylation has been mainly derived from studies of West Nile virus (WNV) and dengue virus (DENV) MTases. The flavivirus genome encodes a single MTase domain, located at the N-terminal one-third of the NS5 protein, which methylates guanosine N-7 and ribose 29-O positions of the viral RNA cap. The C-terminal two-thirds of the NS5 protein contains an RNA-dependent RNA polymerase (RdRp) activity. The flaviviral MTase domain performs the two cap methylations in a sequential manner: N-7 methylation followed by 29-O methylation, i.e. GpppA-RNAAm7GpppA-RNAAm7GpppAm-RNA (Ray et al., 2006) . The sequential cap methylations have been shown in several flaviviruses such as WNV, DENV and yellow fever virus (YFV) (Zhou et al., 2007) .
Distinct RNA elements required for flavivirus N-7 and 29-O methylations
Compared with cellular mRNA cap methylations, flavivirus MTase catalyses its cap methylations with two unique features. First, cellular N-7 and 29-O methylations are catalysed by two separate MTase proteins, while flavivirus N-7 and 29-O methylations are performed by a single MTase protein. Second, cellular MTases catalyse mRNA cap methylation in an RNA sequence-independent manner, while flavivirus MTase catalyses its cap methylations in a viral sequence/structure-dependent manner. Specifically, flavivirus N-7 methylation requires the 59-terminal stemloop structures of viral genomic RNA (especially the second and third nucleotides; Fig. 3a ); the sequence of the stem region is not important. The 29-O methylation requires the first two nucleotides of the genomic RNA and a minimal RNA length of 20 nt (Dong et al., , 2010a . It should be noted that the first two nucleotides of the flavivirus genome (GpppAG) are absolutely conserved (Wengler & Wengler, 1981) and the 59 UTR of the flavivirus genome forms a conserved stem-loop structure (Brinton & Dispoto, 1988) . Furthermore, foot-printing experiments using GpppA-RNA and m7GpppA-RNA showed that the 59 termini of RNA selectively interact with the recombinant NS5 MTase. Specifically, the first three and four nucleotides of the viral RNA substrates were bound by the enzyme during the N-7 and 29-O methylations, respectively; in addition, nucleotides 18-21 of the WNV genomic RNA were bound by recombinant MTase (Dong et al., , 2008d . Since flavivirus methylation requires viral RNA sequence and structure, studies using only cap analogues or non-viral RNA sequence should be avoided, especially when performing biochemical analysis.
Substrate preference determines the sequential order of flavivirus N-7 and 29-O methylations
What dictates the sequential order of N-7 and 29-O methylations? Flavivirus MTase catalyses the two methylations at different optimal pHs in vitro: pH 7.0 for N-7 methylation and pH¢9.0 for 29-O methylation ( Fig. 3b ; Zhou et al., 2007) . Therefore, performing methylation assays in buffers with different pH allows analysis of one type of methylation without being complicated by the other type of methylation. Kinetic analysis showed that WNV MTase performs N-7 methylation at a comparable efficiency when using substrates GpppA-RNA and GpppAm-RNA (i.e. GpppA-RNAAm7GpppA-RNA and GpppAm-RNAA mGpppAm-RNA) (Dong et al., 2008a) . In contrast, the 29-O methylation prefers substrate mGpppA-RNA to substrate GpppA-RNA (i.e. the reaction of m7GpppA-RNAA m7GpppAm-RNA is far more efficient than the reaction of GpppA-RNAAGpppAm-RNA). In agreement with the latter result, cap analogue m7GpppA binds to flavivirus MTase with a higher affinity than cap analogue GpppA (S. P. Lim, unpublished result) . Collectively, the preference of 29-O methylation for a substrate with the N-7 position premethylated, m7GpppA-RNA, is the underlying driving force for the sequential order of N-7 and 29-O methylations. However, whether these in vitro results reflect the in vivo activity during viral replication remains to be determined.
Flavivirus MTase structure
Crystal structures of MTases from many flaviviruses have been solved, including DENV-2 (Egloff et al., 2002b) , WNV (Zhou et al., 2007) , Murray Valley encephalitis virus (MVEV; Assenberg et al., 2007) , Meaban virus (Mastrangelo et al., 2007) , YFV (Geiss et al., 2009) , Modoc virus (Jansson et al., 2009) and Wesselsborn virus (Bollati et al., 2009 ). All flavivirus MTases exhibit a conserved structure consisting of three motifs: (i) an N-terminal domain; (ii) a core domain with a typical structure of SAM-dependent MTase; and (iii) a C-terminal domain (Fig. 4a ). The core domain contains a conserved SAM-binding pocket, a GTP-binding pocket and an RNA-binding site (Fig. 4b) . The K-D-K-E tetrad (Fig. 4c ) forms the active site that is conserved among all 29-O MTases from various organisms. For flavivirus MTase, mutagenesis studies showed that the Asp residue of the K-D-K-E tetrad is essential for both methylation activities; the other three residues of the K-D-K-E tetrad are essential for 29-O methylation, but not for N-7 methylation (Dong et al., 2010a; Ray et al., 2006) . SAM-binding pocket. Flavivirus MTase has a single SAMbinding site (Fig. 4b) , indicating that the SAM molecules bind to this pocket and donate the methyl groups during both methylation reactions. In agreement with the structure result, mutations of the SAM-binding pocket of The structure (in ribbon representation) consists of three subdomains: N-terminal subdomain (red), MTase core (green) and C-terminal subdomain (cyan). SAH is shown in a ball-and-stick representation with carbon in yellow, oxygen in red, nitrogen in blue and sulfur in green. (b) Flavivirus MTase-conserved binding sites for SAH/SAM, GTP and RNA. The surface of WNV MTase is shown as an electrostatic potential map: positively charged residues in blue, negatively charged residues in red and neutral residues in white. The SAH/SAM pocket is shown based on the co-crystal structure of the WNV MTase in complex with SAH (Zhou et al., 2007) . The GTP-binding pocket is modelled through structural alignment with the DENV-2 GTP-SAH-MTase tertiary complex (Egloff et al., 2002b) among different flaviviruses) of the MTase forms a stacking interaction with the guanosine moiety of GTP. Two distinct functions have been proposed for the GTP-binding pocket. First, the GTP pocket binds the guanosine moiety of GTP during the GTase reaction. This hypothesis was initially proposed based on the crystal structure of DENV MTase in complex with cap analogue GpppA (Egloff et al., 2007a) , and was later supported by some experimental evidence (Bollati et al., 2009; Issur et al., 2009) . Second, the GTP pocket binds the N-7 methylated guanosine (m7G) cap during the 29-O methylation reaction. This function is indicated by three lines of evidence. (i) Crystal structures of flavivirus MTase in complex with GTP or cap analogue GpppA showed that the guanosine moiety stacks with residue Phe24/25 and extends the phosphate groups towards the SAM-binding pocket where the 29-O methylation occurs (Assenberg et al., 2007; Egloff et al., 2002b) . (ii) Mutations of the GTP-binding pocket selectively affected 29-O methylation, not N-7 methylation (Dong et al., 2008b; 2010a) . (iii) Addition of GTP to the methylation assay selectively inhibited 29-O methylation activity, suggesting that exogenous GTP competitively binds to the GTP pocket to suppress 29-O methylation. Similarly, ribavirin (a guanosine analogue) 59-triphosphate also selectively inhibits DENV-2 29-O MTase activity; the co-crystal structure showed that ribavirin 59-triphosphate binds to the GTP pocket (Benarroch et al., 2004) . The latter result indicates that, besides multiple known antiviral mechanisms (Leyssen et al., 2005) , ribavirin may also inhibit flavivirus replication through blockage of flaviviral 29-O methylation.
RNA-binding site. Electrostatic potential analysis of flavivirus MTase structures identified a putative RNAbinding site (Fig. 4b ) that is mainly formed by a number of conserved, positively charged residues. Mutagenesis studies showed that distinct sets of amino acids within the putative RNA-binding site are required for N-7 and 29-O methylations. The exact positioning of RNA substrate on the RNAbinding site remains to be determined during the two methylation reactions. Co-crystal structures of the enzyme in a complex of m7GpppA-RNA or GpppA-RNA are critical to reveal this information. It should be noted that the crystal structure of DENV-3 MTase in complex with a 59 capped RNA (GpppAGAACCUG) was solved (Yap et al., 2010) . The structure shows that two RNA molecules are encircled by four MTase monomers around a twofold noncrystallography symmetry axis; only two of the four monomers make direct contact with the 59 end of RNA. This structure may represent the product of guanylylation of the viral genome prior to the subsequent methylation events that require repositioning of the RNA substrate to reach the methyl-donor sites.
A molecule reposition model for flavivirus RNA cap methylation
How could flavivirus MTase with one methyl donor (SAMbinding pocket) catalyse two distinct N-7 and 29-O methylation reactions? A molecule reposition model (Dong et al., 2008b) was proposed to consolidate the structure and mutagenesis results discussed above. As shown in Fig. 5 , during N-7 methylation, the guanine N-7 of GpppA-RNA substrate is first positioned next to the methyl group of SAM to generate m7GpppA-RNA. Upon N-7 methylation, the RNA substrate is repositioned on the enzyme surface so that the m7G moiety of the m7GpppA-RNA binds to the GTP pocket. In this way, the 29-OH of the adenosine ribose of m7GpppA-RNA registers next to SAM for 29-O methylation, generating m7GpppAm-RNA.
It is not known whether the reposition model is performed by one or two MTase molecules during the two methylation reactions. If one MTase molecule catalyses two reactions, repositioning of the RNA substrate should coordinate with a replenishment of SAH with SAM, in preparation for the second methylation (Fig. 5a ). If two MTase molecules are involved, m7GpppA-RNA has to dissociate from the first MTase after the N-7 methylation, and then bind to a second MTase to perform the 29-O methylation (Fig. 5b) . The two-molecule model is supported by the result that two distinct mutant MTases (one defective in N-7 methylation and another defective in 29-O methylation) could trans complement with each other to complete the GpppA-RNAAm7GpppAm-RNA double methylation reaction (Dong et al., 2008a) . Structure studies of MVEV MTase also support the two-molecule model (Assenberg et al., 2007) . This RNA-enzyme dissociationand-association process is similar to the capping process of reovirus and bluetongue viruses, in which the N-7 and 29-O methylations are sequentially performed by two separate MTase domains within a large polyprotein (Reinisch et al., 2000; Sutton et al., 2007) . However, it should be noted that the one-molecule model should be more energetically favoured than the two-molecule model because it avoids the RNA-protein dissociation-and-association events. For both one-and two-molecule models, repositioning of m7GpppA-RNA on the original enzyme (one-molecule model) or dissociation from the original enzyme (twomolecule model) may be regulated by the release of byproduct SAH after the N-7 methylation.
Flavivirus internal RNA methylation
Flavivirus NS5 is recently found to harbour an internal RNA methylation activity (Dong et al., 2012) . Recombinant full-length NS5 or the MTase domain of DENV can methylate viral RNA without a 59 cap structure. Mutagenesis analysis showed that the MTase K-D-K-E tetrad serves as the active site for internal methylation. In contrast to cap methylations which require specific viral RNA sequence/structure, flavivirus internal methylation does not require viral RNA sequence or structure. Non-viral RNA or synthetic polyA (but not polyG, polyC or polyU) can also be methylated. RNAs with all adenosines premethylated to 29-O methyladenosines (Am) are not active substrates for internal methylations, indicating that the internal methylation occurs at the 29-OH position of adenosine. Mass spectroscopic analysis further demonstrated that the internal methylation product is 29-O methyladenosine. Importantly, mass spectroscopic study showed that genomic RNA purified from the WT DENV particles contained internal 29-O methyladenosines, whereas genomic RNA purified from the 29-O methylation defective virus (containing an E217A mutation of the MTase K-D-K-E tetrad) did not have internal 29-O methyladenosines. It should be noted that the internal methylation activity of flavivirus MTase is much lower than cap methylation activity. Interestingly, flavivirus MTase can methylate host tRNA and ribosome rRNA in vitro, suggesting that viral MTase may modulate host RNA in the infected cells. Internal RNA 29-O methylation is found in cellular splicesomal small nuclear RNAs (snRNAs) and rRNAs of cells; such modification regulates mRNA splicing, translation or decay, through interplay with RNA-binding proteins and microRNAs. The biological function of flavivirus internal methylation and the significance of its ability to methylate host RNA remain to be determined.
Genetic and physical interactions between flavivirus MTase and RdRp domains
A revertant analysis was performed using a lethal WNV (containing a D146S mutation of the K-D-K-E tetrad) that was completely defective in N-7 methylation (Zhang et al., 2008) . Sequencing of the revertant viruses revealed two adaptive mutations, K61Q in MTase and W751R in RdRp. Analysis of recombinant WNVs showed that the D146S substitution alone was lethal for viral replication; the GpppA-RNA is first positioned next to the methyl group of SAM to generate m7GpppA-RNA. After N-7 methylation, the SAH molecule is replenished by a new SAM molecule; the m7G moiety of m7GpppA-RNA is repositioned into the GTP-binding pocket; the repositioned m7GpppA-RNA precisely registers the ribose 29-OH of the first transcribed adenosine with SAM, generating m7GpppAm-RNA. (b) Two-MTase model. The N-7 methylation occurs as described for the one-MTase model (a). Upon N-7 methylation, the m7GpppA-RNA molecule dissociates from the first MTase and reassociates with a second MTase molecule. When binding to the second MTase, the m7G moiety of m7GpppA-RNA binds to the GTP pocket and generates m7GpppAm-RNA. The SAM and GTP pockets are represented by an oval and rectangle, respectively. compensatory mutations rescued viral replication. Biochemical analysis showed that a low level of N-7 methylation of the D146S MTase is essential for the recovery of revertant viruses; the K61Q mutation facilitates viral replication through improvement of N-7 methylation; the RdRp W751R mutation improves viral replication through enhancement of polymerase activity. Collectively, the results raise the possibility that mutation(s) within RdRp that enhances the polymerase activity could potentially rescue the replication defect that is caused by an inhibitor (when such a compound is identified in the future; see below) of N-7 methylation.
Different models have been proposed for intra-molecular interactions between flavivirus MTase and RdRp domains in the context of full-length NS5. The discrepancy is due to different methods used to map the interaction, including in silico docking in combination with revertant mapping (Malet et al., 2007) , small-angle X-ray scattering (Bussetta and Choi, 2012) and crystallography (Lu & Gong, 2013) . Specifically, in silico docking and reverse genetic analyses using WNV NS5 suggest a cooperative model in which the MTase domain is located in front of the RdRp domain; once newly synthesized RNA exits from the 'RNA exit tunnel' of RdRp (located in the front of RdRp), the 59 end of RNA is ready for the capping process (Malet et al., 2007) . The small-angle X-ray scattering study using DENV NS5 suggests an elongated side-by-side model in which the MTase domain is located next to the finger subdomain of RdRp (Bussetta & Choi, 2012) . The crystal structure of fulllength NS5 of Japanese encephalitis virus (JEV) shows that the MTase domain is attached to the backside of the RdRp through key hydrophobic interactions, shielding the topright rim of the 'NTP entry channel' (Lu & Gong, 2013) . Biochemical and mutagenesis analyses are needed to define the relevance of these structural conformations during distinct steps of viral RNA synthesis and cap modification.
Targeting flavivirus MTase and GTase for antiviral development
N-7 MTase is essential for flavivirus replication
The function of cap methylation has been extensively studied using genome-length RNA and replicon RNA of WNV (Dong et al., 2008c) and DENV (Dong et al., 2010a; Kroschewski et al., 2008) . Compared with a WNV replicon without a 59 cap (i.e. pppA-RNA), RNA with a 59 GpppA, m7GpppA or m7GpppAm cap increased the translation level by approximately 16-, 25-and 25-fold, respectively. These results suggest that (i) the guanine cap is essential for translation; (ii) N-7 cap methylation enhances translation efficiency; and (iii) 29-O methylation does not contribute to viral translation. Mutagenesis analysis showed that mutations that ablated N-7 MTase activity were lethal for flavivirus replication; in contrast, mutations that abolished 29-O MTase activity did not ablate viral replication in Vero cells (defective in IFN production). These results have provided genetic evidence that N-7 MTase is a potential antiviral target.
Rational design of selective inhibitor of flavivirus MTase
The core domain of SAM-dependent MTase is conserved among host and viral enzymes. It is therefore a challenge to design inhibitors that selectively suppress flavivirus MTase without affecting host MTases. A close analysis of flavivirus MTase structure uncovered a hydrophobic cavity located next to the SAM-binding pocket (Fig. 6a) (Dong et al., 2010b) . This cavity is conserved among all flavivirus MTases, and is not found in various host MTases. Chemical modification of SAH with substituents that extend into the identified cavity generated inhibitors (exemplified by compound 10; Fig. 6b ) that showed improved and selective activity against DENV MTase, but not against related human enzymes (Fig. 6c) (Lim et al., 2011) . The crystal structure of DENV MTase in complex with an SAH derivative (compound 10) confirmed that its N6-substituent bound in this cavity (Fig. 6d ) and induced conformational changes in residues lining the pocket (Fig.  6e) . These results demonstrate that targeting structural features unique to viral MTase can generate selective inhibitors without affecting host MTases. Further studies are needed to improve the cell permeability of these compounds and to show antiviral activity in cell culture.
A panel of nucleoside analogues containing thymidine base were recently reported to have selective inhibition against WNV MTase (Chen et al., 2013b) . Although the potency was low [with K i (the dissociation constant of an enzymeinhibitor complex) values of 24.2 mM and 3.9 mM for N-7 and 29-O methylations, respectively, for the most potent compound GRL-002], the compounds did not inhibit human RNA MTase even at 300 mM. Molecule modelling suggests that these compounds could potentially bind to the SAM-binding pocket with specific interactions with the MTase residues. For further development, the potency of these compounds needs to be significantly improved.
Inhibition of flavivirus GTase (and 29-O MTase) through targeting the GTP pocket of MTase domain
Since the GTP pocket is essential in binding substrate GTP during the GTase reaction, Geiss et al. (2011) developed an assay to screen for inhibitors that can displace GTP from the DENV MTase domain. After screening 235 456 compounds, they identified a class of compounds that could compete against GTP binding to the GTP pocket, with IC 50 values of single-digit micromolar concentration. The compounds showed double-digit micromolar EC 50 values in DENV-2 replicon cells, with an undesirable therapeutic index (TI) of ,10 (Stahla-Beek et al., 2012). Interestingly, the compounds specifically inhibited flaviviruses Kunjin virus and YFV, but not alphavirus Sindbis virus, in viral titre reduction assays. Although the potency remains to be improved, these compounds represent a reasonable chemistry starting point for further development. As mentioned above, since the GTP pocket participates in 29-O methylation, it remains to be differentiated how much antiviral activity of the compounds was contributed by blocking the 29-O methylation and by blocking the GTase activity.
Functions of 2 §-O methylation in evasion of innate immune response
Although 29-O methylation was discovered more than 35 years ago, the function has been elusive until recently. We and others have demonstrated that the 29-O methylation is required to escape the IFN-mediated innate immune response in host cells. Infection with 29-O MTase mutant mouse hepatitis virus (MHV; a coronavirus) resulted in increased levels of IFN production in cell culture; mechanistically, the 29-O MTase mutant MHV was recognized by the cytosolic innate immune receptor MDA5, leading to the upregulation of IFN-b expression (Züst et al., 2011) . In contrast, cells infected by WT or mutant 29-O MTase WNV produced equivalent levels of IFN, indicating that the WNV RNA without 29-O methylation does not potentiate IFN production (Daffis et al., 2010) . However, the 29-O MTase-defective mutants of WNV, MHV and vaccinia virus (an enveloped DNA virus belonging to the poxvirus family) were shown to be more sensitive to antiviral inhibition by IFIT1 (IFNinduced proteins with tetra-tricopeptide repeats) than the WT viruses. Using IFIT1 knockout mice, Szretter et al.
(2012) showed that WT WNV could largely evade the antiviral effect of IFIT1, whereas the 29-O MTase mutant WNV was restricted in vivo by IFIT1-dependent and -independent mechanisms in different cell types. More recently, Kimura et al. (2013) reported that IFIT1 inhibited JEV through binding to the 59 capped RNA without 29-O methylation. The binding of IFIT1 to 29-O-unmethylated capped RNA impairs the loading of eukaryotic translation initiation factors to the 29-O-unmethylated RNA template, leading to selective inhibition of viral RNA translation (Habjan et al., 2013) . Collectively, methylation studies of members from different virus families have provided an evolutionary explanation for the 29-O methylation of eukaryotic mRNA: to function as a molecular pattern recognition signal to distinguish self from non-self RNA during viral infection. Many viruses that replicate in the cytoplasm have evolved their own RNA-modifying enzymes to mimic cellular mRNA to evade host innate immune suppression.
§-O MTase mutant flaviviruses as a vaccine approach
The discovery that the 29-O methylation of flavivirus RNA cap is an immune evasion strategy to hide from the host cell's innate immune recognition provides a new way to (Lim et al., 2011). attenuate viruses by targeting the MTase. A cytoplasmic virus defective in 29-O methylation is replicative; but its viral RNA lacks 29-O methylation, and is recognized and subsequently eliminated by the host immune response. Such mutant viruses could be rationally designed as a live attenuated vaccine. Using JEV and DENV, we recently showed that 29-O MTase-defective viruses could be rationally designed as a new approach for live attenuated flavivirus vaccine development. For both viruses, mutants carrying a GluAAla substitution in the K-D-K-E tetrad (E218A and E217A for JEV and DENV-2, respectively) were attenuated in mice and in monkeys, while being sufficiently immunogenic to generate a protective immune response Züst et al., 2013) .
JEV 29-O MTase E218A mutant JEV was attenuated in 129 mice (Fig. 7a ). Its virulence was restored in the A129 mice (defective in type I IFN receptor) ( Fig. 7b) . In BALB/c mice, inoculation (intraperitoneal, i.p.) of 4610 7 p.f.u. WT JEV killed the mice, whereas neither morbidity nor mortality was observed in the mice inoculated with an equal amount of 29-O MTase mutant virus . Compared with the WT JEV, the neurovirulence of mutant JEV was attenuated by about 24-fold, as indicated by the LD 50 values: 7.9 p.f.u. for the WT and 188.4 p.f.u. for the mutant virus. Mice immunized with 1610 4 p.f.u. mutant virus were fully protected from challenge with 1610 8 p.f.u. WT SA14 or SX06 JEV strains. Neutralizing antibodies and specific T-cells were induced in the immunized mice . In cell culture, the mutant JEV was more sensitive than the WT virus to IFN inhibition (Fig. 7c ).
DENV-2
Similar to JEV, 29-O MTase E217A mutant DENV-2 was more sensitive to IFN suppression than the WT virus ( Fig.  8a) . Rhesus monkeys immunized with 1610 3 , 1610 4 or 1610 5 p.f.u. of a 29-O MTase mutant DENV-2 produced neutralizing antibody titres that were in the range of other live attenuated vaccine candidates currently under development (Fig. 8b) . After challenging the animals with 1610 5 p.f.u. WT DENV-2, all monkeys across the three immunization groups were fully protected with no detectable viraemia. The results indicate that as little as 1610 3 p.f.u. and one dose of immunization were fully protective (Züst et al., 2013) . These results are encouraging, but will have to be repeated by extending the time between immunization and challenge to address how long the protection lasts. An immunization schedule that requires only one dose would be an optimal solution for travellers and to reduce cost in endemic countries. Interestingly, mosquitoes feeding on blood containing the mutant DENV-2 were not infected, whereas mosquitoes feeding on blood containing the WT virus were infected and thus able to transmit it (Züst et al., 2013) .
There is no established correlate of protection for DENV vaccine development. The vaccine efficacy study with CYD dengue vaccine in Thailand has confirmed that the neutralization antibody titres are not necessarily predictive for protection. Despite equal neutralizing titres against all four serotypes of DENV in vaccinated individuals, the efficacy was only 9.2 % for DENV-2 compared with 100 % protection for DENV-4 (Sabchareon et al., 2012) . are essential for protection because they bind viral particles to block infection of target cells. The CD8 + T-cell response in dengue patients is predominantly NS3-and NS5-specific (Duangchinda et al., 2010; Simmons et al., 2005) , whereas CD4 + T helper cells are more diverse, with specificity to both structural and non-structural proteins (Rivino et al., 2013) . The importance of both CD4 + and CD8 + T-cells for protection has been convincingly shown in mouse models, where it is possible to specifically deplete individual cell types and to dissect the role of CD4 + and CD8 + T-cells (Yauch et al., 2009 (Yauch et al., , 2010 . Moreover, in a human dengue challenge model, IFN-c-producing CD8 + T-cells were associated with protection (Gunther et al., 2011) . Furthermore, the CYD tetravalent formulation seems to have been protective for DENV-4 in the Thailand trial (Sabchareon et al., 2012) . In two independent cohorts, the CD4 + T-cell response to DENV-4 was highest and most long-lasting after the third dose in vaccinated individuals (Guy and Almond, 2008) . Taken together, these findings are evidence for a contribution of both serotype-specific B-and T-cells to full protection and to the maintenance of immune memory after DENV infection. A tetravalent vaccine containing 29-O MTase mutant DENV-1, -2, -3 and -4 covers the nonstructural proteins of all four serotypes of DENV to generate T-cell responses specific for all four serotypes, which can potentially improve efficacy.
The possibility to introduce targeted mutations by reverse genetics enables generation of recombinant viruses based on the circulating virus strains or based on the geographical prevalence of viral genotypes. Reversion of mutations is a concern for using the recombinant 29-O MTase mutant virus for vaccine development. So far, continuous passaging of the current 29-O mutant JEV and DENV in cell culture or viruses recovered from the immunized mice and monkeys did not show any reversion. The risk of reversion can be minimized by introducing multiple amino acid changes in the vaccine candidates, such that, even if a particular amino acid reverts back to WT, additional attenuating amino acids will still be present in the virus genome. Deletions in the viral 39 UTR sequences may also be further incorporated to enhance the attenuated phenotype (Hanley et al., 2004) . Besides minimizing the reversion risk on the virus side, the production of attenuated vaccines can also be made safer by introducing new technologies for quality control. In particular, nextgeneration sequencing technology can be very useful to make the manufacturing of attenuated viruses safer. During large-scale production, even a very small number of virus revertants could be detected with deep sequencing technology because of its higher sensitivity compared with PCR/sequencing techniques.
Outlook
Although significant progress has been made in understanding the flavivirus RNA cap formation during the past decade, many important questions remain elusive. (i) The identity of the GTase needs to be clearly demonstrated for flavivirus capping. Compared with GTases from other organisms, the currently reported GTase from flavivirus NS5 was very weak (Issur et al., 2009 ). In addition, the covalent linkage of GMP to flavivirus NS5 protein upon incubation with GTP is not specific: when incubated with a 32 P-labelled ATP, CTP or UTP, recombinant NS5 could also be 32 P-labelled (H. Dong, unpublished results) . It is likely that NS5 needs an unknown co-factor(s) to potentiate its GTase activity. (ii) A mechanism needs to be defined to coordinate the various enzymes required to form the type-1 cap structure. The NS3 RTPase and NS5 GTase/MTase are components of the viral replication complex. How do these enzymes orchestrate RNA synthesis and cap formation? Capping of cellular mRNA is coupled to RNA synthesis through direct binding of the capping apparatus to the RNA polymerase II elongation complex McCracken et al., 1997; Yue et al., 1997) . It is also likely that flavivirus RNA capping and methylation are coupled to RNA synthesis. The recent crystal structure of full-length NS5 of JEV represents the first step to reveal the relative conformation between the MTase and RdRp domains (Lu & Gong, 2013) . More biochemical and structural studies are needed to define the interaction between viral RNA synthesis and capping. (iii) The exact mechanism of flavivirus N-7 and 29-O methylation remains to be illuminated at an atomic level. Since flavivirus MTase requires distinct viral RNA elements, it is challenging to obtain co-crystal structures of MTase in complex with RNA substrates. The structure information will greatly facilitate rational design of antiviral inhibitors as well as design of 29-O MTase mutant viruses for vaccine development. (iv) It remains to be demonstrated whether the 59 end of minus-strand flaviviral RNA is capped and/or methylated. If not, how does the viral capping apparatus differentiate between the minus-and plus-strand RNAs?
For antiviral development, more effort should be made to inhibit flavivirus MTase. Besides targeting the hydrophobic pocket next to the SAM-binding site (Lim et al., 2011) , the GTP-binding pocket could also be used for the design of an antiviral inhibitor. Although the GTP pocket functions at the step of 29-O methylation (which is not essential for viral replication), its potential role in GTase (which should be essential for viral replication) justifies the effort to target this pocket. Since the crystallization procedure has been well established for flavivirus MTase, small-molecule fragment-based screening followed by co-crystallization could be pursued to design and synthesize inhibitors of this enzyme.
The mechanism by which 29-O cap methylation evades host immune response remains to be further investigated.
What are the differentiating viral elements that enhance IFN production in cells infected with MHV but not WNV 29-O MTase (Daffis et al., 2010) ? Is IFIT1 the only host restriction factor to sense RNA without 29-O cap methylation? Can the prototype results generated with WNV 29-O MTase be applied to other flaviviruses? The answers to these questions will greatly enhance our understanding of the biology of RNA methylation as well as allow us to apply the knowledge to develop medical intervention.
